cations during the covered period. The issue was discovered while preparing the CY 2023 financial disclosure report and was promptly rectified. Safeguards have since been implemented to ensure all future transactions are timely reported. Abbott Laboratories Common Stock (ABT)

Rep. Jared Moskowitz disclosed that the filer sold · $1,001 – $15,000 · Owner: Filer

Disclosures are reported transactions, not verified real-time portfolio holdings.